Published in J Virol on November 01, 1996
Genome-wide analysis of vaccinia virus protein-protein interactions. Proc Natl Acad Sci U S A (2000) 2.81
Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene. J Virol (1998) 1.50
Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes. J Virol (2001) 1.39
The nucleoside triphosphatase and helicase activities of vaccinia virus NPH-II are essential for virus replication. J Virol (1998) 1.38
Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J Virol (2001) 1.28
Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants. J Virol (2001) 1.26
The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase. J Virol (2001) 1.26
Crystal structure of vaccinia virus uracil-DNA glycosylase reveals dimeric assembly. BMC Struct Biol (2007) 1.15
Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. Virol J (2005) 1.09
Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylase. Nucleic Acids Res (2003) 1.01
HIV DNA is heavily uracilated, which protects it from autointegration. Proc Natl Acad Sci U S A (2011) 1.00
Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme. J Biol Chem (2011) 0.99
Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA. J Virol (2010) 0.98
Uracil-DNA glycosylases-structural and functional perspectives on an essential family of DNA repair enzymes. Protein Sci (2014) 0.95
Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach. Antiviral Res (2008) 0.91
Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies. PLoS One (2009) 0.90
Uracil within DNA: an actor of antiviral immunity. Retrovirology (2008) 0.89
Crystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the A20 N-terminal domain. PLoS Pathog (2014) 0.85
Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4. J Med Chem (2011) 0.85
Crystal Structure of the Vaccinia Virus Uracil-DNA Glycosylase in Complex with DNA. J Biol Chem (2015) 0.81
Poxvirus uracil-DNA glycosylase-An unusual member of the family I uracil-DNA glycosylases. Protein Sci (2016) 0.75
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
The complete DNA sequence of vaccinia virus. Virology (1990) 7.76
Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature (1996) 4.95
Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell (1995) 3.36
Regulation of vaccinia virus transcription. Annu Rev Biochem (1990) 3.01
Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UNG encodes the major uracil-DNA glycosylase. Biochemistry (1995) 2.91
Analysis of the complete nucleotide sequence of African swine fever virus. Virology (1995) 2.68
The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature (1995) 2.49
DNA polymerase beta conducts the gap-filling step in uracil-initiated base excision repair in a bovine testis nuclear extract. J Biol Chem (1995) 2.42
A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A (1991) 2.27
Nucleotide sequence and genetic map of the 16-kb vaccinia virus HindIII D fragment. Virology (1986) 2.25
The mechanism of cytoplasmic orthopoxvirus DNA replication. Cell (1981) 2.16
Molecular cloning of human uracil-DNA glycosylase, a highly conserved DNA repair enzyme. EMBO J (1989) 2.15
Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: protein mimicry of DNA. Cell (1995) 2.11
Cytoplasmic transcription system encoded by vaccinia virus. J Biol Chem (1991) 1.96
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J Virol (1996) 1.90
Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells. Proc Natl Acad Sci U S A (1986) 1.71
Molecular cloning and primary structure of the uracil-DNA-glycosylase gene from Saccharomyces cerevisiae. J Biol Chem (1989) 1.69
Gene UL2 of herpes simplex virus type 1 encodes a uracil-DNA glycosylase. J Gen Virol (1989) 1.52
Isolation of insertion, deletion, and nonsense mutations of the uracil-DNA glycosylase (ung) gene of Escherichia coli K-12. J Bacteriol (1985) 1.49
A poxvirus-encoded uracil DNA glycosylase is essential for virus viability. J Virol (1993) 1.45
Identification of the coding sequence for herpes simplex virus uracil-DNA glycosylase. J Virol (1988) 1.41
Partial purification and characterization of a uracil DNA N-glycosidase from Bacillus subtilis. Biochemistry (1977) 1.36
Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase. J Biol Chem (1989) 1.36
The vaccinia virus-encoded uracil DNA glycosylase has an essential role in viral DNA replication. Virology (1994) 1.32
Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J Virol (1994) 1.30
Identification of a poxvirus gene encoding a uracil DNA glycosylase. Proc Natl Acad Sci U S A (1993) 1.25
Uracil in OriS of herpes simplex 1 alters its specific recognition by origin binding protein (OBP): does virus induced uracil-DNA glycosylase play a key role in viral reactivation and replication? Chromosoma (1992) 1.25
Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology (1996) 1.24
Activity profiles of enzymes that control the uracil incorporation into DNA during neuronal development. Mutat Res (1990) 1.23
Poxviruses: an emerging portrait of biological strategy. Cell (1990) 1.20
Isolation of a herpes simplex virus cDNA encoding the DNA repair enzyme uracil-DNA glycosylase. J Virol (1987) 1.16
Initiation and termination of vaccinia virus DNA replication. Virology (1981) 1.15
Characterization of the Escherichia coli uracil-DNA glycosylase.inhibitor protein complex. J Biol Chem (1992) 1.11
Uracil-DNA glycosylases and DNA uracil repair. Int Rev Cytol (1989) 1.09
Investigation of vaccinia virus DNA replication employing a conditional lethal mutant defective in DNA. Virology (1984) 1.07
Cell cycle regulation of a human cyclin-like gene encoding uracil-DNA glycosylase. J Biol Chem (1993) 1.04
Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology (1992) 1.04
Vaccinia virus DNA replication: two hundred base pairs of telomeric sequence confer optimal replication efficiency on minichromosome templates. Proc Natl Acad Sci U S A (1996) 1.03
Biogenesis of poxviruses: preliminary characterization of conditional lethal mutants of vaccinia virus defective in DNA synthesis. Virology (1980) 1.02
Elimination of naturally occurring crosslinks in vaccinia virus DNA after viral penetration into cells. Proc Natl Acad Sci U S A (1977) 1.01
Cell cycle regulation and subcellular localization of the major human uracil-DNA glycosylase. Exp Cell Res (1995) 0.99
Physical association of the human base-excision repair enzyme uracil DNA glycosylase with the 70,000-dalton catalytic subunit of DNA polymerase alpha. Proc Natl Acad Sci U S A (1986) 0.98
The role of telomeres in poxvirus DNA replication. Curr Top Microbiol Immunol (1990) 0.96
A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution. J Virol (1991) 0.96
Specificity of the bacteriophage PBS2 induced inhibitor of uracil-DNA glycosylase. Biochemistry (1981) 0.95
Nucleotide sequence analysis of a 10.5 kbp HindIII fragment of fowlpox virus: relatedness to the central portion of the vaccinia virus HindIII D region. J Gen Virol (1990) 0.89
Quantitative assays for uracil-DNA glycosylase of high sensitivity. Biochem Cell Biol (1988) 0.86
Identification of human herpesvirus 6 uracil-DNA glycosylase gene. J Gen Virol (1994) 0.86
DNA synthesis enzymes and proliferating cell nuclear antigen in normal and neoplastic nerve cells. Anticancer Res (1992) 0.84
Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron (1990) 3.70
The complete DNA sequence of myxoma virus. Virology (1999) 2.44
Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol (1988) 2.40
Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology (1978) 2.09
Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science (1992) 2.07
Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation (1996) 1.86
Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol (2000) 1.86
Modulating chemokines: more lessons from viruses. Immunol Today (2000) 1.85
Apoptosis: an innate immune response to virus infection. Trends Microbiol (1999) 1.82
The complete genome sequence of shope (rabbit) fibroma virus. Virology (1999) 1.73
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72
Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells. Proc Natl Acad Sci U S A (1986) 1.71
T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun (1991) 1.64
Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology (1995) 1.64
Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J Virol (1992) 1.59
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
The site-specific cleavage of synthetic Holliday junction analogs and related branched DNA structures by bacteriophage T7 endonuclease I. J Biol Chem (1987) 1.52
High levels of genetic recombination among cotransfected plasmid DNAs in poxvirus-infected mammalian cells. J Virol (1988) 1.50
SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology (1993) 1.49
A poxvirus-encoded uracil DNA glycosylase is essential for virus viability. J Virol (1993) 1.45
Use of chemokine receptors by poxviruses. Science (1999) 1.43
The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol (1997) 1.43
M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med (2000) 1.39
Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology (1991) 1.39
Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology (1990) 1.38
Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol (1996) 1.37
Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J Virol (2005) 1.33
Biogenesis of poxviruses: mirror-image deletions in vaccinia virus DNA. Cell (1979) 1.30
Immunomodulation by viruses: the myxoma virus story. Immunol Rev (1999) 1.28
Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development. Neuroscience (2006) 1.27
Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc Natl Acad Sci U S A (1996) 1.27
Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology (1996) 1.27
Identification of a poxvirus gene encoding a uracil DNA glycosylase. Proc Natl Acad Sci U S A (1993) 1.25
Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology (1996) 1.24
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells. Leukemia (2009) 1.22
Mechanism of replication of phi x174 single-stranded DNA. IX. Requirement for the Escherichia coli dnaG protein. J Virol (1974) 1.21
Identification and DNA sequence of the large subunit of the capping enzyme from Shope fibroma virus. Virology (1991) 1.19
The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Mol Cell Biol (1987) 1.19
Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J Virol (1987) 1.16
Physical characterization and molecular cloning of the Shope fibroma virus DNA genome. Virology (1983) 1.16
A site-directed approach for constructing temperature-sensitive ubiquitin-conjugating enzymes reveals a cell cycle function and growth function for RAD6. J Biol Chem (1991) 1.16
Tumorigenic poxviruses: analysis of viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus. Virology (1986) 1.16
Random-hole optical fiber evanescent-wave gas sensing. Opt Lett (2004) 1.15
Immunomodulatory proteins of myxoma virus. Semin Immunol (2001) 1.14
Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy (2008) 1.14
The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest (2000) 1.12
Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus. J Virol (1986) 1.09
Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology (1987) 1.09
Nocardia infection in kidney transplant recipients: case report and analysis of 66 published cases. Transpl Infect Dis (2011) 1.07
Cruciform extrusion in plasmids bearing the replicative intermediate configuration of a poxvirus telomere. J Mol Biol (1987) 1.07
The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. J Biol Chem (1995) 1.07
Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology (1998) 1.06
Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem (1993) 1.06
The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology (1997) 1.06
Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res (2000) 1.06
Biogenesis of poxviruses: role for the DNA-dependent RNA polymerase II of the host during expression of late functions. Proc Natl Acad Sci U S A (1979) 1.05
The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter. J Virol (1991) 1.04
Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology (1992) 1.04
The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion. Virology (1994) 1.03
Efficient resolution of replicated poxvirus telomeres to native hairpin structures requires two inverted symmetrical copies of a core target DNA sequence. J Virol (1987) 1.03
Biogenesis of poxviruses: preliminary characterization of conditional lethal mutants of vaccinia virus defective in DNA synthesis. Virology (1980) 1.02
An Arabidopsis mutant cex1 exhibits constant accumulation of jasmonate-regulated AtVSP, Thi2.1 and PDF1.2. FEBS Lett (2001) 1.02
Cloning and sequencing of the cytoplasmic precursor to the alpha subunit of rat liver mitochondrial succinyl-CoA synthetase. Proc Natl Acad Sci U S A (1988) 1.02
Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1. J Biol Chem (1998) 1.01
Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc Natl Acad Sci U S A (2001) 1.01
Optical detection of triggered atherosclerotic plaque disruption by fluorescence emission analysis. Photochem Photobiol (2000) 1.01
Tumorigenic poxviruses: genomic organization of malignant rabbit virus, a recombinant between Shope fibroma virus and myxoma virus. Virology (1985) 1.01
Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int J Gynecol Cancer (2007) 1.00
Evidence that the majority of leucine transfer ribonucleic acid is not involved in repression in Salmonella typhimurium. J Bacteriol (1971) 1.00
Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology (1999) 1.00
Viruses and apoptosis: meddling with mitochondria. Virology (2001) 1.00
Reconstruction with callus distraction for nonunion with bone loss and leg shortening caused by suppurative osteomyelitis of the femur. J Bone Joint Surg Br (2007) 1.00
Construction of microsatellite-based linkage maps and identification of size-related quantitative trait loci for Zhikong scallop (Chlamys farreri). Anim Genet (2009) 1.00
Tumorigenic poxviruses: construction of the composite physical map of the Shope fibroma virus genome. J Virol (1984) 1.00
Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J Immunol (1992) 0.99
Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int (2007) 0.99
The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. Mutat Res (2001) 0.99
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status. Oncogene (2010) 0.98
Secreted poxvirus chemokine binding proteins. J Leukoc Biol (1997) 0.98
In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease. J Virol (1992) 0.98
Alternatively spliced hBRF variants function at different RNA polymerase III promoters. EMBO J (2000) 0.97
Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor. J Rheumatol (1996) 0.97
Poxvirus infection rapidly activates tyrosine kinase signal transduction. J Biol Chem (2001) 0.96
The role of telomeres in poxvirus DNA replication. Curr Top Microbiol Immunol (1990) 0.96
Apoptosis regulators from DNA viruses. Curr Opin Immunol (1998) 0.95
Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J Virol (1997) 0.95
Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFalpha, but the dimer is a more potent TNF inhibitor. J Biol Chem (1996) 0.95
A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories. J Virol (1994) 0.94
Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev (2000) 0.93
Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes. J Virol (1995) 0.93
Cloning of the vaccinia virus telomere in a yeast plasmid vector. Gene (1984) 0.91
Deletion of the growth factor gene related to EGF and TGF alpha reduces virulence of malignant rabbit fibroma virus. Virology (1992) 0.91
Prenatal identification of i(Yp) by molecular cytogenetic analysis. Prenat Diagn (1995) 0.91
Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis. Virology (1999) 0.91
Molecular mechanisms of nickel carcinogenesis. Toxicol Lett (2002) 0.90
Role of Fosinopril and Valsartan on Klotho Gene Expression Induced by Angiotensin II in Rat Renal Tubular Epithelial Cells. Kidney Blood Press Res (2010) 0.90
Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. Brain Res Dev Brain Res (2001) 0.90
Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice. Gene Ther (2010) 0.90
Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin. Circulation (2000) 0.89
Virus encoded cytokines and cytokine receptors. Parasitology (1997) 0.89